Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates. Review uri icon

Overview

publication date

  • April 11, 2026

Identity

Digital Object Identifier (DOI)

  • 10.1007/s11934-026-01330-7

PubMed ID

  • 41964855

Additional Document Info

volume

  • 27

issue

  • 1